Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Warr

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivorsLouise Bordeleau, Kathleen I Pritchard, Charles L Loprinzi, et al.
The Journal of Pain|November 28, 2012
The communal coping model and cancer pain: the roles of catastrophizing and attachment styleLynn R Gauthier, Gary Rodin, Camilla Zimmermann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the artSteven M Grunberg, David Warr, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 23, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyJørn Herrstedt, Fausto Roila, David Warr, et al.
Journal of Pain and Symptom Management|December 26, 2007
What patients with cancer want to know about pain: a qualitative studyJacqueline L Bender, Joanne Hohenadel, Jennifer Wong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2010
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)Fausto Roila, David Warr, Matti Aapro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2005
Evidence-based recommendations for the use of antiemetics in radiotherapyErnesto Maranzano, Petra Ch Feyer, Alexander Molassiotis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 2020
Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, CanadaRobert C Grant, Coleman Rotstein, Geoffrey Liu, et al.
The Journal of Pain|March 8, 2017
Psychometric Evaluation of the Pain Attitudes Questionnaire-Revised for People With Advanced CancerKenneth Mah, Kim T Tran, Lynn R Gauthier, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivorsLouise Bordeleau, Kathleen I Pritchard, Charles L Loprinzi, et al.
The Journal of Pain|November 28, 2012
The communal coping model and cancer pain: the roles of catastrophizing and attachment styleLynn R Gauthier, Gary Rodin, Camilla Zimmermann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the artSteven M Grunberg, David Warr, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 23, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyJørn Herrstedt, Fausto Roila, David Warr, et al.
Journal of Pain and Symptom Management|December 26, 2007
What patients with cancer want to know about pain: a qualitative studyJacqueline L Bender, Joanne Hohenadel, Jennifer Wong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2010
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)Fausto Roila, David Warr, Matti Aapro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2005
Evidence-based recommendations for the use of antiemetics in radiotherapyErnesto Maranzano, Petra Ch Feyer, Alexander Molassiotis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 2020
Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, CanadaRobert C Grant, Coleman Rotstein, Geoffrey Liu, et al.
The Journal of Pain|March 8, 2017
Psychometric Evaluation of the Pain Attitudes Questionnaire-Revised for People With Advanced CancerKenneth Mah, Kim T Tran, Lynn R Gauthier, et al.
Pageof 4